\-\ Texto\\:\\ \ \(0\)\
\-\ pale\\,\\ tachypneic\\,\\ grunting\\ infant\\.\\ she\\ has\\ a\\ constant\\ s3\\ gallop\\ and\\ 2\\-3\\/6\\ blowing\\ systolic\\ regurgitant\\ murmur\\ at\\ the\\ apex\\ radiating\\ to\\ the\\ left\\ lung\\ field\\.\\ there\\ is\\ moderate\\ hepatosplenomegaly\\ measuring\\ 4\\ cm\\ below\\ the\\ right\\ costal\\ margin\\.\\ \ \(0\)\
\-\ vitals\\-\\ bp\\:\\ 88\\/52\\ pulse\\:\\ 160\\ bpm\\ respiratory\\ rate\\:\\ 34\\ breaths\\/min\\ spo2\\:\\ 88\\%\\ on\\ room\\ air\ \(0\)\
\-\ capillary\\ blood\\ gas\\-\\ ph\\:\\ 7\\.387\\,\\ pco2\\:\\ 49\\.1\\ mmhg\\,\\ po2\\:\\ 57\\.3\\ mmhg\\,\\ hco3\\:\\ 28\\.9\\,\\ base\\ excess\\:\\ 3\\.1\ \(0\)\
\-\ ekg\\ was\\ interpreted\\ a\\ sinus\\ tachycardia\\ with\\ biventricular\\ hypertrophy\ \(0\)\
\-\ labs\\ were\\ notable\\ for\\ anemia\\ \\(hct\\ of\\ 29\\)\ \(0\)\
\-\ was\\ positive\\ for\\ rsv\\,\\ rhinovirus\\,\\ and\\ enterovirus\ \(0\)\
\-\ the\\ patient\\ was\\ treated\\ for\\ congestive\\ failure\\ initially\ \(0\)\
\-\ the\\ origin\\ of\\ the\\ left\\ coronary\\ artery\\ is\\ demonstrated\ \(0\)\
\-\ arising\\ anomalously\\ from\\ the\\ left\\ pulmonary\\ artery\\.\\ contrast\\ in\\ the\\ right\\ coronary\\ artery\\ is\\ as\\ dense\\ as\\ the\\ aorta\\ where\\ it\\ originates\\ and\\ the\\ lower\\ density\\ of\\ the\\ left\\ coronary\\ corresponds\\ with\\ the\\ lower\\ density\\ of\\ the\\ pulmonary\\ artery\\ from\\ which\\ it\\ originates\\.\\ severe\\ cardiomegaly\\ is\ \(0\)\
\-\ demonstrated\\ with\\ left\\ ventricular\\ enlargement\\ and\\ small\\ pericardial\ \(1\)\
\-\ effusion\\.\ \(128\)\
\-\ alcapa\\,\\ bland\\ white\\ garland\\ syndrome\ \(0\)\
\-\ viral\\ pericarditis\\ vs\\ congenital\\ heart\\ anomaly\\ vs\\ dilated\\ cardiomyopathy\ \(0\)\
\-\ two\\ month\\ old\\ female\\ presents\\ for\\ well\\ child\\ check\\ and\\ is\\ transferred\\ to\\ er\\ with\\ respiratory\\ distress\\,\\ grunting\\,\\ poor\\ weight\\ gain\\,\\ hypoxia\\,\\ and\\ low\\ o2\\ saturation\ \(0\)\
\-\ anomalous\\ origin\\ of\\ the\\ left\\ coronary\\ artery\\ from\\ the\\ pulmonary\\ artery\\ \\(alcapa\\)\\,\\ also\\ known\\ as\\ bland\\-white\\-garland\\ syndrome\\,\\ is\\ a\\ rare\\ but\\ serious\\ congenital\\ cardiac\\ anomaly\\.\\ the\\ alcapa\\ anomaly\\ may\\ result\\ from\\ \\(1\\)\\ abnormal\\ septation\\ of\\ the\\ conotruncus\\ into\\ the\\ aorta\\ and\\ pulmonary\\ artery\\,\\ or\\ from\\ \\(2\\)\\ persistence\\ of\\ the\\ pulmonary\\ buds\\ together\\ with\\ involution\\ of\\ the\\ aortic\\ buds\\ that\\ eventually\\ form\\ the\\ coronary\\ arteries\\.\\ alcapa\\ is\\ usually\\ an\\ isolated\\ cardiac\\ anomaly\\ but\\,\\ in\\ rare\\ incidences\\,\\ has\\ been\\ described\\ with\\ patent\\ ductus\\ arteriosus\\,\\ ventricular\\ septal\\ defect\\,\\ tetrology\\ of\\ fallot\\,\\ and\\ coarctation\\ of\\ the\\ aorta\\.\\ \ \(0\)\
\-\ the\\ pathophysiology\\ behind\\ alcapa\\ stems\\ from\\ chronic\\ myocardial\\ ischemia\\ leading\\ to\\ the\\ combination\\ of\\ left\\ ventricular\\ dysfunction\\ and\\ significant\\ mitral\\ valve\\ insufficiency\\,\\ which\\ eventually\\ presents\\ as\\ congestive\\ heart\\ failure\\ \\(chf\\)\\ symptoms\\ \\(eg\\,\\ tachypnea\\,\\ poor\\ feeding\\,\\ irritability\\,\\ diaphoresis\\)\\ in\\ the\\ young\\ infant\\.\\ alcapa\\ is\\ undetected\\ in\\ utero\\ because\\ the\\ fetus\\ benefits\\ from\\ the\\ favorable\\ fetal\\ physiology\\ that\\ includes\\ \\(1\\)\\ equivalent\\ pressures\\ in\\ the\\ main\\ pulmonary\\ artery\\ and\\ aorta\\ secondary\\ to\\ a\\ nonrestrictive\\ patent\\ ductus\\ arteriosus\\,\\ and\\ \\(2\\)\\ relatively\\ similar\\ oxygen\\ concentrations\\ due\\ to\\ parallel\\ circulations\\.\\ after\\ birth\\,\\ pulmonary\\ artery\\ pressure\\/resistance\\ and\\ oxygen\\ content\\ of\\ the\\ pulmonary\\ blood\\ flow\\ both\\ decrease\\.\\ this\\ leads\\ to\\ myocardial\\ ischemia\\ due\\ to\\ the\\ left\\ ventricle\\ being\\ perfused\\ by\\ desaturated\\ blood\\ under\\ low\\ pressure\\.\\ initially\\ there\\ is\\ only\\ a\\ transient\\ demand\\ ischemia\\,\\ but\\ eventually\\ collateral\\ circulation\\ between\\ the\\ right\\ and\\ left\\ coronary\\ systems\\ ensues\\.\\ this\\ leads\\ to\\ left\\ coronary\\ artery\\ flow\\ reversing\\ and\\ entering\\ the\\ pulmonic\\ trunk\\ due\\ to\\ the\\ low\\ pulmonary\\ vascular\\ resistance\\ \\(coronary\\ steal\\ phenomena\\)\\.\\ \\[1\\]\ \(0\)\
\-\ the\\ etiology\\ of\\ alcapa\\ is\\ not\\ considered\\ an\\ inheritable\\ congenital\\ cardiac\\ defect\\ \\.\\ the\\ condition\\ is\\ generally\\ considered\\ to\\ be\\ on\\ the\\ basis\\ of\\ multi\\ factorial\\ inheritance\\,\\ similar\\ to\\ other\\ congenital\\ heart\\ defects\\.\\ in\\ utero\\ exposure\\ to\\ teratogens\\,\\ chromosomal\\ abnormalities\\,\\ or\\ other\\ risk\\ factors\\ are\\ unrelated\\ to\\ alcapa\\.\\ other\\ congenital\\ cardiac\\ defects\\,\\ such\\ as\\ patent\\ ductus\\ arteriosus\\,\\ ventricular\\ septal\\ defect\\,\\ tetralogy\\ of\\ fallot\\,\\ or\\ coarctation\\ of\\ the\\ aorta\\,\\ rarely\\ may\\ be\\ associated\\ with\\ alcapa\\.\\ no\\ specific\\ association\\ with\\ any\\ noncardiac\\ anomalies\\ is\\ noted\\.\\ alcapa\\ has\\ no\\ race\\ or\\ gender\\ predilectation\\.\\ \\[2\\]\ \(0\)\
\-\ anomalous\\ origin\\ of\\ the\\ left\\ coronary\\ artery\\ from\\ the\\ pulmonary\\ artery\\ \\(alcapa\\)\\ is\\ a\\ rare\\,\\ congenital\\ cardiac\\ anomaly\\ accounting\\ for\\ approximately\\ 0\\.25\\-0\\.5\\%\\ of\\ all\\ congenital\\ heart\\ disease\\.\\ \\[3\\]\\ if\\ left\\ untreated\\ however\\,\\ the\\ mortality\\ rate\\ in\\ the\\ first\\ year\\ of\\ life\\ is\\ 90\\%\\ secondary\\ to\\ myocardial\\ ischemia\\ or\\ infarction\\ and\\ mitral\\ valve\\ insufficiency\\ leading\\ to\\ chf\\.\\ sudden\\ death\\ may\\ occur\\ because\\ of\\ inadequate\\ collateral\\ circulation\\ between\\ the\\ left\\ and\\ right\\ coronary\\ artery\\ systems\\ and\\/or\\ development\\ of\\ arrhythmia\\.\\ early\\ diagnosis\\ using\\ echocardiography\\ with\\ color\\ flow\\ mapping\\ and\\ improvements\\ in\\ surgical\\ techniques\\ \\(eg\\,\\ myocardial\\ preservation\\)\\ dramatically\\ improve\\ prognosis\\.\ \(0\)\
\-\ a\\ high\\ index\\ of\\ suspicion\\ is\\ necessary\\ to\\ make\\ the\\ diagnosis\\ of\\ alcapa\\,\\ as\\ surgical\\ treatment\\ is\\ extremely\\ successful\\ and\\ results\\ in\\ an\\ excellent\\ long\\-term\\ prognosis\\.\\ the\\ most\\ serious\\,\\ yet\\ avoidable\\,\\ complication\\ is\\ the\\ mistaking\\ of\\ symptoms\\ in\\ the\\ patient\\ older\\ than\\ several\\ months\\ who\\ presents\\ with\\ anomalous\\ left\\ coronary\\ artery\\ from\\ the\\ pulmonary\\ artery\\ \\(alcapa\\)\\ as\\ idiopathic\\ dilated\\ cardiomyopathy\\ or\\ end\\ stage\\ myocarditis\\.\\ the\\ initial\\ presentation\\ may\\ be\\ entirely\\ similar\\ but\\ the\\ treatments\\ are\\ dramatically\\ different\\.\\ the\\ clinical\\ and\\ initial\\ laboratory\\ findings\\ may\\ be\\ remarkably\\ similar\\.\\ for\\ those\\ reasons\\,\\ careful\\ definition\\ of\\ the\\ origin\\ of\\ the\\ coronary\\ arteries\\ by\\ echo\\-doppler\\ ultrasonographic\\ studies\\ in\\ every\\ patient\\ presenting\\ with\\ the\\ above\\ clinical\\ scenario\\ should\\ be\\ undertaken\\.\\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ mesurolle\\ b\\,\\ qanadli\\ sd\\,\\ mignon\\ f\\,\\ lacombe\\ p\\.\\ anomalous\\ origin\\ of\\ the\\ left\\ coronary\\ artery\\ arising\\ from\\ the\\ pulmonary\\ trunk\\.\\ ajr\\ am\\ j\\ roentgenol\\.\\ 2006\\ apr\\.\\ 186\\(4\\)\\:1202\\;\\ \\(issn\\:\\ 0361\\-803x\\)\ \(0\)\
\-\ 2\\.\\ secinaro\\ a\\,\\ ntsinjana\\ h\\,\\ tann\\ o\\,\\ schuler\\ pk\\,\\ muthurangu\\ v\\,\\ hughes\\ m\\,\\ et\\ al\\.\\ cardiovascular\\ magnetic\\ resonance\\ findings\\ in\\ repaired\\ anomalous\\ left\\ coronary\\ artery\\ to\\ pulmonary\\ artery\\ connection\\ \\(alcapa\\)\\.\\ j\\ cardiovasc\\ magn\\ reson\\.\\ 2011\\ may\\ 16\\.\\ 13\\:27\\.\\ \\ pmcid\\:\\ pmc3123558\ \(0\)\
\-\ 3\\.\\ pachon\\ r\\,\\ bravo\\ c\\,\\ neimeiera\\ m\\.\\ anomalous\\ origin\\ of\\ the\\ left\\ coronary\\ artery\\ from\\ pulmonary\\ artery\ \(0\)\
\-\ \\(alcapa\\)\\.\\ j\\ clin\\ exp\\ cardiolog\\ 2014\\,\\ 5\\:10\\.\\ doi\\:\\ 10\\.4172\\/2155\\-9880\\.1000341\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ alcapa\\:\\ 0\\.12098864811429821\ \(0\)\
\-\ coronary\\:\\ 0\\.07162142858094381\ \(0\)\
\-\ artery\\:\\ 0\\.05053684194852431\ \(0\)\
\-\ pulmonary\\:\\ 0\\.034708743141093235\ \(0\)\
\-\ anomalous\\:\\ 0\\.029713269279905086\ \(0\)\
\-\ origin\\:\\ 0\\.023342673032863477\ \(0\)\
\-\ congenital\\:\\ 0\\.021724044476163915\ \(0\)\
\-\ anomaly\\:\\ 0\\.02100571472341572\ \(0\)\
\-\ myocardial\\:\\ 0\\.02078252029994196\ \(0\)\
\-\ ductus\\:\\ 0\\.018621357695645366\ \(0\)\
\-\ aorta\\:\\ 0\\.01821263131654938\ \(0\)\
\-\ arteriosus\\:\\ 0\\.018195039392842963\ \(0\)\
\-\ cardiac\\:\\ 0\\.016161056568773438\ \(0\)\
\-\ left\\:\\ 0\\.016140803949989624\ \(0\)\
\-\ ischemia\\:\\ 0\\.0157749010427325\ \(0\)\
\-\ buds\\:\\ 0\\.01532652658450524\ \(0\)\
\-\ ventricular\\:\\ 0\\.015167055214309368\ \(0\)\
\-\ \\,\\:\\ 0\\.01505438298805173\ \(0\)\
\-\ \\:\\:\\ 0\\.014591432579819905\ \(0\)\
\-\ eventually\\:\\ 0\\.014015822918946933\ \(0\)\
\-\ from\\:\\ 0\\.013833955158586231\ \(0\)\
\-\ grunting\\:\\ 0\\.013378504234928822\ \(0\)\
\-\ dramatically\\:\\ 0\\.013378504234928822\ \(0\)\
\-\ \\]\\:\\ 0\\.013321885805698553\ \(0\)\
\-\ similar\\:\\ 0\\.013313551614462316\ \(0\)\
\-\ \\[\\:\\ 0\\.01328344467907718\ \(0\)\
\-\ fallot\\:\\ 0\\.012746024133402438\ \(0\)\
\-\ patent\\:\\ 0\\.012543242019796643\ \(0\)\
\-\ heart\\:\\ 0\\.011793762259816381\ \(0\)\
\-\ cardiomyopathy\\:\\ 0\\.011767917906793116\ \(0\)\
\-\ coarctation\\:\\ 0\\.011767917906793116\ \(0\)\
\-\ originates\\:\\ 0\\.011558661669141027\ \(0\)\
\-\ j\\:\\ 0\\.011498584011018583\ \(0\)\
\-\ \\(\\:\\ 0\\.011477445501392024\ \(0\)\
\-\ utero\\:\\ 0\\.011369366376580302\ \(0\)\
\-\ \\)\\:\\ 0\\.011337242377172672\ \(0\)\
\-\ may\\:\\ 0\\.011167795643881573\ \(0\)\
\-\ serious\\:\\ 0\\.010890395062147555\ \(0\)\
\-\ trunk\\:\\ 0\\.010688244725881533\ \(0\)\
\-\ chf\\:\\ 0\\.01062518872128455\ \(0\)\
\-\ congestive\\:\\ 0\\.010504782322443569\ \(0\)\
\-\ mitral\\:\\ 0\\.01039126014997098\ \(0\)\
\-\ mmhg\\:\\ 0\\.010336843120798954\ \(0\)\
\-\ circulation\\:\\ 0\\.010336843120798954\ \(0\)\
\-\ eg\\:\\ 0\\.01018200391231889\ \(0\)\
\-\ rare\\:\\ 0\\.009885849648480525\ \(0\)\
\-\ oxygen\\:\\ 0\\.009738819103353231\ \(0\)\
\-\ defect\\:\\ 0\\.009529535232273864\ \(0\)\
\-\ is\\:\\ 0\\.009492495762204902\ \(0\)\
\-\ leads\\:\\ 0\\.00947858422270496\ \(0\)\
\-\ septal\\:\\ 0\\.009248530964462414\ \(0\)\
\-\ insufficiency\\:\\ 0\\.009014602393148843\ \(0\)\
\-\ systems\\:\\ 0\\.009014602393148843\ \(0\)\
\-\ as\\:\\ 0\\.008985146515649349\ \(0\)\
\-\ collateral\\:\\ 0\\.008881257203799035\ \(0\)\
\-\ 2\\-3\\/6\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ 88\\/52\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ gas\\-\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ 7\\.387\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ 49\\.1\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ 57\\.3\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ bland\\-white\\-garland\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ conotruncus\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ stems\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ nonrestrictive\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ pressure\\/resistance\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ desaturated\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ reversing\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ factorial\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ predilectation\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ 0\\.25\\-0\\.5\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ mistaking\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ echo\\-doppler\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ mesurolle\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ qanadli\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ mignon\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ \\:1202\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ 0361\\-803x\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ secinaro\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ ntsinjana\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ tann\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ schuler\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ pk\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ muthurangu\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ magn\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ reson\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ 13\\:27\\.\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ pmc3123558\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ pachon\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ bravo\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ neimeiera\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ cardiolog\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ 5\\:10\\.\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ 10\\.4172\\/2155\\-9880\\.1000341\\:\\ 0\\.008754238752697615\ \(0\)\
\-\ valve\\:\\ 0\\.008485051919953315\ \(0\)\
\-\ flow\\:\\ 0\\.008413268749330237\ \(0\)\
\-\ leading\\:\\ 0\\.008119425233871217\ \(0\)\
\-\ vitals\\-\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ breaths\\/min\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ enterovirus\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ garland\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ circulations\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ demand\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ ensues\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ inheritable\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ teratogens\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ avoidable\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ lacombe\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ issn\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ pmcid\\:\\ 0\\.008065909874286547\ \(0\)\
\-\ prognosis\\:\\ 0\\.008050336621983598\ \(0\)\
\-\ infant\\:\\ 0\\.008033433564053293\ \(0\)\
\-\ defects\\:\\ 0\\.007795768213991548\ \(0\)\
\-\ the\\:\\ 0\\.007688142942803421\ \(0\)\
\-\ regurgitant\\:\\ 0\\.00766326329225262\ \(0\)\
\-\ 28\\.9\\:\\ 0\\.00766326329225262\ \(0\)\
\-\ rhinovirus\\:\\ 0\\.00766326329225262\ \(0\)\
\-\ anomalously\\:\\ 0\\.00766326329225262\ \(0\)\
\-\ incidences\\:\\ 0\\.00766326329225262\ \(0\)\
\-\ tetrology\\:\\ 0\\.00766326329225262\ \(0\)\
\-\ multi\\:\\ 0\\.00766326329225262\ \(0\)\
\-\ hughes\\:\\ 0\\.00766326329225262\ \(0\)\
\-\ poor\\:\\ 0\\.007637944636326708\ \(0\)\
\-\ biventricular\\:\\ 0\\.007377580995875479\ \(0\)\
\-\ remarkably\\:\\ 0\\.007377580995875479\ \(0\)\
\-\ sd\\:\\ 0\\.007377580995875479\ \(0\)\
\-\ 186\\:\\ 0\\.007377580995875479\ \(0\)\
\-\ cardiovasc\\:\\ 0\\.007377580995875479\ \(0\)\
\-\ exp\\:\\ 0\\.007377580995875479\ \(0\)\
\-\ but\\:\\ 0\\.007239337839259335\ \(0\)\
\-\ to\\:\\ 0\\.00720969001343671\ \(0\)\
\-\ pco2\\:\\ 0\\.007155988591392649\ \(0\)\
\-\ involution\\:\\ 0\\.007155988591392649\ \(0\)\
\-\ inheritance\\:\\ 0\\.007155988591392649\ \(0\)\
\-\ improvements\\:\\ 0\\.007155988591392649\ \(0\)\
\-\ low\\:\\ 0\\.007078951498112412\ \(0\)\
\-\ respiratory\\:\\ 0\\.007045998540026157\ \(0\)\
\-\ arising\\:\\ 0\\.007025628132544153\ \(0\)\
\-\ arteries\\:\\ 0\\.007025628132544153\ \(0\)\
\-\ blowing\\:\\ 0\\.006974934413841552\ \(0\)\
\-\ rsv\\:\\ 0\\.006974934413841552\ \(0\)\
\-\ physiology\\:\\ 0\\.006974934413841552\ \(0\)\
\-\ noncardiac\\:\\ 0\\.006974934413841552\ \(0\)\
\-\ myocarditis\\:\\ 0\\.006974934413841552\ \(0\)\
\-\ blood\\:\\ 0\\.006948593066065441\ \(0\)\
\-\ initially\\:\\ 0\\.006907607436475035\ \(0\)\
\-\ considered\\:\\ 0\\.006851126929383608\ \(0\)\
\-\ undetected\\:\\ 0\\.006821855287895914\ \(0\)\
\-\ steal\\:\\ 0\\.006821855287895914\ \(0\)\
\-\ due\\:\\ 0\\.006793278509293465\ \(0\)\
\-\ gallop\\:\\ 0\\.006689252117464411\ \(0\)\
\-\ po2\\:\\ 0\\.006689252117464411\ \(0\)\
\-\ hco3\\:\\ 0\\.006689252117464411\ \(0\)\
\-\ bland\\:\\ 0\\.006689252117464411\ \(0\)\
\-\ doi\\:\\ 0\\.006689252117464411\ \(0\)\
\-\ vs\\:\\ 0\\.006682184648263749\ \(0\)\
\-\ failure\\:\\ 0\\.006648377920221185\ \(0\)\
\-\ rate\\:\\ 0\\.006615137021799092\ \(0\)\
\-\ tachypneic\\:\\ 0\\.006572287831807625\ \(0\)\
\-\ concentrations\\:\\ 0\\.006572287831807625\ \(0\)\
\-\ perfused\\:\\ 0\\.006572287831807625\ \(0\)\
\-\ arrhythmia\\:\\ 0\\.006572287831807625\ \(0\)\
\-\ be\\:\\ 0\\.0065429827375567485\ \(0\)\
\-\ race\\:\\ 0\\.0064676597129815815\ \(0\)\
\-\ mapping\\:\\ 0\\.0064676597129815815\ \(0\)\
\-\ ultrasonographic\\:\\ 0\\.0064676597129815815\ \(0\)\
\-\ septation\\:\\ 0\\.006373012066701219\ \(0\)\
\-\ diaphoresis\\:\\ 0\\.006373012066701219\ \(0\)\
\-\ pulmonic\\:\\ 0\\.006373012066701219\ \(0\)\
\-\ tetralogy\\:\\ 0\\.006373012066701219\ \(0\)\
\-\ 160\\:\\ 0\\.006286605535430484\ \(0\)\
\-\ irritability\\:\\ 0\\.006286605535430484\ \(0\)\
\-\ phenomena\\:\\ 0\\.006286605535430484\ \(0\)\
\-\ chromosomal\\:\\ 0\\.006286605535430484\ \(0\)\
\-\ s3\\:\\ 0\\.006207119231881789\ \(0\)\
\-\ costal\\:\\ 0\\.006207119231881789\ \(0\)\
\-\ scenario\\:\\ 0\\.006207119231881789\ \(0\)\
\-\ apr\\:\\ 0\\.006207119231881789\ \(0\)\
\-\ dilated\\:\\ 0\\.006167013717163115\ \(0\)\
\-\ equivalent\\:\\ 0\\.006133526409484846\ \(0\)\
\-\ undertaken\\:\\ 0\\.006133526409484846\ \(0\)\
\-\ 1\\:\\ 0\\.006057576071379465\ \(0\)\
\-\ or\\:\\ 0\\.005967364939207791\ \(0\)\
\-\ roentgenol\\:\\ 0\\.005940720039632852\ \(0\)\
\-\ \\%\\:\\ 0\\.0059383943396604\ \(0\)\
\-\ because\\:\\ 0\\.005937474312981227\ \(0\)\
\-\ pericarditis\\:\\ 0\\.005883958953396558\ \(0\)\
\-\ other\\:\\ 0\\.005867840760781873\ \(0\)\
\-\ spo2\\:\\ 0\\.005830267571797476\ \(0\)\
\-\ 2014\\:\\ 0\\.005830267571797476\ \(0\)\
\-\ accounting\\:\\ 0\\.0057793308345705134\ \(0\)\
\-\ 3\\.1\\:\\ 0\\.005730879827450918\ \(0\)\
\-\ gain\\:\\ 0\\.005730879827450918\ \(0\)\
\-\ content\\:\\ 0\\.005730879827450918\ \(0\)\
\-\ entering\\:\\ 0\\.005730879827450918\ \(0\)\
\-\ resistance\\:\\ 0\\.005730879827450918\ \(0\)\
\-\ excess\\:\\ 0\\.005684683188290151\ \(0\)\
\-\ check\\:\\ 0\\.005684683188290151\ \(0\)\
\-\ pathophysiology\\:\\ 0\\.005684683188290151\ \(0\)\
\-\ gender\\:\\ 0\\.005684683188290151\ \(0\)\
\-\ pale\\:\\ 0\\.005640540425061915\ \(0\)\
\-\ persistence\\:\\ 0\\.005640540425061915\ \(0\)\
\-\ inadequate\\:\\ 0\\.005640540425061915\ \(0\)\
\-\ initial\\:\\ 0\\.005623797702640135\ \(0\)\
\-\ hepatosplenomegaly\\:\\ 0\\.005598276657019416\ \(0\)\
\-\ benefits\\:\\ 0\\.005598276657019416\ \(0\)\
\-\ untreated\\:\\ 0\\.005598276657019416\ \(0\)\
\-\ p\\.\\:\\ 0\\.005598276657019416\ \(0\)\
\-\ density\\:\\ 0\\.00558417349922534\ \(0\)\
\-\ 88\\:\\ 0\\.005557738430087684\ \(0\)\
\-\ ph\\:\\ 0\\.005557738430087684\ \(0\)\
\-\ favorable\\:\\ 0\\.0055187903534707206\ \(0\)\
\-\ pressures\\:\\ 0\\.0055187903534707206\ \(0\)\
\-\ unrelated\\:\\ 0\\.0055187903534707206\ \(0\)\
\-\ 2\\:\\ 0\\.0054819399101605154\ \(0\)\
\-\ bpm\\:\\ 0\\.00548131237136263\ \(0\)\
\-\ together\\:\\ 0\\.0054451975310737775\ \(0\)\
\-\ corresponds\\:\\ 0\\.00541035014297917\ \(0\)\
\-\ echocardiography\\:\\ 0\\.00541035014297917\ \(0\)\
\-\ ajr\\:\\ 0\\.00541035014297917\ \(0\)\
\-\ between\\:\\ 0\\.005379335722391745\ \(0\)\
\-\ hypoxia\\:\\ 0\\.005376684252536586\ \(0\)\
\-\ parallel\\:\\ 0\\.005376684252536586\ \(0\)\
\-\ definition\\:\\ 0\\.005376684252536586\ \(0\)\
\-\ 2011\\:\\ 0\\.005376684252536586\ \(0\)\
\-\ interpreted\\:\\ 0\\.005344122362940767\ \(0\)\
\-\ careful\\:\\ 0\\.005312594360642275\ \(0\)\
\-\ repaired\\:\\ 0\\.0052820366062562235\ \(0\)\
\-\ preservation\\:\\ 0\\.005223605126590948\ \(0\)\
\-\ connection\\:\\ 0\\.005223605126590948\ \(0\)\
\-\ clinical\\:\\ 0\\.005222065144123146\ \(0\)\
\-\ presents\\:\\ 0\\.005200529182248042\ \(0\)\
\-\ entirely\\:\\ 0\\.00519563007498549\ \(0\)\
\-\ constant\\:\\ 0\\.005168421560399477\ \(0\)\
\-\ o\\:\\ 0\\.005168421560399477\ \(0\)\
\-\ ekg\\:\\ 0\\.005116143771436795\ \(0\)\
\-\ basis\\:\\ 0\\.005091001956159445\ \(0\)\
\-\ techniques\\:\\ 0\\.005066480990329881\ \(0\)\
\-\ tachypnea\\:\\ 0\\.00504255094903985\ \(0\)\
\-\ reasons\\:\\ 0\\.00504255094903985\ \(0\)\
\-\ in\\:\\ 0\\.0050216154535085\ \(0\)\
\-\ capillary\\:\\ 0\\.004996354309879083\ \(0\)\
\-\ saturation\\:\\ 0\\.004996354309879083\ \(0\)\
\-\ clin\\:\\ 0\\.004996354309879083\ \(0\)\
\-\ demonstrated\\:\\ 0\\.004979980104184642\ \(0\)\
\-\ resonance\\:\\ 0\\.00497403767050266\ \(0\)\
\-\ m\\.\\:\\ 0\\.00497403767050266\ \(0\)\
\-\ cardiomegaly\\:\\ 0\\.004952211546650847\ \(0\)\
\-\ fetus\\:\\ 0\\.004952211546650847\ \(0\)\
\-\ index\\:\\ 0\\.004930854838387726\ \(0\)\
\-\ treatments\\:\\ 0\\.004909947778608349\ \(0\)\
\-\ 2006\\:\\ 0\\.004889471823094212\ \(0\)\
\-\ o2\\:\\ 0\\.004869409551676616\ \(0\)\
\-\ magnetic\\:\\ 0\\.004869409551676616\ \(0\)\
\-\ syndrome\\:\\ 0\\.004853836299373668\ \(0\)\
\-\ excellent\\:\\ 0\\.004849744579187857\ \(0\)\
\-\ tachycardia\\:\\ 0\\.0048304614750596525\ \(0\)\
\-\ extremely\\:\\ 0\\.0048304614750596525\ \(0\)\
\-\ has\\:\\ 0\\.004780635463240153\ \(0\)\
\-\ yet\\:\\ 0\\.0047568686526627095\ \(0\)\
\-\ cardiovascular\\:\\ 0\\.0047568686526627095\ \(0\)\
\-\ secondary\\:\\ 0\\.004744846010941028\ \(0\)\
\-\ 4\\:\\ 0\\.004728841916939514\ \(0\)\
\-\ systolic\\:\\ 0\\.0047220212645681025\ \(0\)\
\-\ notable\\:\\ 0\\.004688355374125519\ \(0\)\
\-\ long\\-term\\:\\ 0\\.004688355374125519\ \(0\)\
\-\ v\\:\\ 0\\.0046557934845296986\ \(0\)\
\-\ mortality\\:\\ 0\\.004624265482231207\ \(0\)\
\-\ hct\\:\\ 0\\.004608869070576823\ \(0\)\
\-\ transient\\:\\ 0\\.004593707727845156\ \(0\)\
\-\ death\\:\\ 0\\.004578774383888314\ \(0\)\
\-\ pericardial\\:\\ 0\\.0045640622828107165\ \(0\)\
\-\ transferred\\:\\ 0\\.0045640622828107165\ \(0\)\
\-\ radiating\\:\\ 0\\.00454956496461692\ \(0\)\
\-\ make\\:\\ 0\\.00453527624817988\ \(0\)\
\-\ dysfunction\\:\\ 0\\.004521190215417262\ \(0\)\
\-\ improve\\:\\ 0\\.004521190215417262\ \(0\)\
\-\ successful\\:\\ 0\\.004521190215417262\ \(0\)\
\-\ every\\:\\ 0\\.004507301196574422\ \(0\)\
\-\ behind\\:\\ 0\\.004480092681988409\ \(0\)\
\-\ h\\:\\ 0\\.004466762969642689\ \(0\)\
\-\ anomalies\\:\\ 0\\.0044406286018995175\ \(0\)\
\-\ 29\\:\\ 0\\.004427814893025727\ \(0\)\
\-\ f\\:\\ 0\\.004427814893025727\ \(0\)\
\-\ isolated\\:\\ 0\\.004415164420555588\ \(0\)\
\-\ exposure\\:\\ 0\\.004415164420555588\ \(0\)\
\-\ suspicion\\:\\ 0\\.004402673077748377\ \(0\)\
\-\ murmur\\:\\ 0\\.0043903369109176355\ \(0\)\
\-\ pulse\\:\\ 0\\.004378152111918813\ \(0\)\
\-\ m\\:\\ 0\\.004378152111918813\ \(0\)\
\-\ apex\\:\\ 0\\.004366115011092254\ \(0\)\
\-\ hypertrophy\\:\\ 0\\.004366115011092254\ \(0\)\
\-\ am\\:\\ 0\\.004366115011092254\ \(0\)\
\-\ field\\:\\ 0\\.004354222070628783\ \(0\)\
\-\ feeding\\:\\ 0\\.004354222070628783\ \(0\)\
\-\ for\\:\\ 0\\.004344239217334947\ \(0\)\
\-\ fetal\\:\\ 0\\.004319374682534175\ \(0\)\
\-\ end\\:\\ 0\\.004308025431468015\ \(0\)\
\-\ viral\\:\\ 0\\.004274735767080088\ \(0\)\
\-\ combination\\:\\ 0\\.004274735767080088\ \(0\)\
\-\ older\\:\\ 0\\.004274735767080088\ \(0\)\
\-\ symptoms\\:\\ 0\\.0042297070047629375\ \(0\)\
\-\ anemia\\:\\ 0\\.004221618900197281\ \(0\)\
\-\ 34\\:\\ 0\\.0042113281484241465\ \(0\)\
\-\ different\\:\\ 0\\.004201142944683144\ \(0\)\
\-\ complication\\:\\ 0\\.004161415700776789\ \(0\)\
\-\ color\\:\\ 0\\.004142132596648585\ \(0\)\
\-\ association\\:\\ 0\\.004123216812169247\ \(0\)\
\-\ birth\\:\\ 0\\.004077446099954483\ \(0\)\
\-\ rarely\\:\\ 0\\.0040685397742516415\ \(0\)\
\-\ c\\:\\ 0\\.0040336923861570345\ \(0\)\
\-\ dense\\:\\ 0\\.004008336574831151\ \(0\)\
\-\ 90\\:\\ 0\\.0040000264957144515\ \(0\)\
\-\ b\\:\\ 0\\.0040000264957144515\ \(0\)\
\-\ margin\\:\\ 0\\.003991785380704823\ \(0\)\
\-\ form\\:\\ 0\\.0039674646061186305\ \(0\)\
\-\ main\\:\\ 0\\.003951575488594856\ \(0\)\
\-\ sudden\\:\\ 0\\.003920540192165756\ \(0\)\
\-\ diagnosis\\:\\ 0\\.003897158551698947\ \(0\)\
\-\ decrease\\:\\ 0\\.003883062210057665\ \(0\)\
\-\ idiopathic\\:\\ 0\\.0038684582901076198\ \(0\)\
\-\ those\\:\\ 0\\.0038612360862058524\ \(0\)\
\-\ r\\:\\ 0\\.0038540660286353586\ \(0\)\
\-\ 16\\:\\ 0\\.0038398793779427305\ \(0\)\
\-\ generally\\:\\ 0\\.003818972318163354\ \(0\)\
\-\ lower\\:\\ 0\\.0038170051030066783\ \(0\)\
\-\ it\\:\\ 0\\.0038149918262820586\ \(0\)\
\-\ factors\\:\\ 0\\.003812099981674204\ \(0\)\
\-\ necessary\\:\\ 0\\.0037587691187428622\ \(0\)\
\-\ child\\:\\ 0\\.00371434419933731\ \(0\)\
\-\ under\\:\\ 0\\.0037081569602602136\ \(0\)\
\-\ life\\:\\ 0\\.0037020080325065683\ \(0\)\
\-\ young\\:\\ 0\\.0036958969445479006\ \(0\)\
\-\ development\\:\\ 0\\.0036958969445479006\ \(0\)\
\-\ below\\:\\ 0\\.0036837864449512587\ \(0\)\
\-\ bp\\:\\ 0\\.0036837864449512587\ \(0\)\
\-\ using\\:\\ 0\\.0036837864449512587\ \(0\)\
\-\ room\\:\\ 0\\.0036483166509074854\ \(0\)\
\-\ relatively\\:\\ 0\\.0036310458041231074\ \(0\)\
\-\ stage\\:\\ 0\\.003619696553056948\ \(0\)\
\-\ described\\:\\ 0\\.00361407019999272\ \(0\)\
\-\ findings\\:\\ 0\\.003612387161449771\ \(0\)\
\-\ al\\:\\ 0\\.003597379913680524\ \(0\)\
\-\ etiology\\:\\ 0\\.0035918782449857723\ \(0\)\
\-\ and\\/or\\:\\ 0\\.0035864068886690193\ \(0\)\
\-\ right\\:\\ 0\\.003581456639961933\ \(0\)\
\-\ distress\\:\\ 0\\.0035755537898287115\ \(0\)\
\-\ surgical\\:\\ 0\\.0035674712418102355\ \(0\)\
\-\ condition\\:\\ 0\\.003548928906560929\ \(0\)\
\-\ references\\:\\ 0\\.003528131315850658\ \(0\)\
\-\ an\\:\\ 0\\.00352035212795848\ \(0\)\
\-\ specific\\:\\ 0\\.0035077603726201686\ \(0\)\
\-\ et\\:\\ 0\\.0034730868223657218\ \(0\)\
\-\ infarction\\:\\ 0\\.0034682308290249152\ \(0\)\
\-\ where\\:\\ 0\\.0034633984659155083\ \(0\)\
\-\ presenting\\:\\ 0\\.0034585895041719253\ \(0\)\
\-\ aortic\\:\\ 0\\.003434887933758178\ \(0\)\
\-\ results\\:\\ 0\\.003425563464691804\ \(0\)\
\-\ includes\\:\\ 0\\.003420933858827046\ \(0\)\
\-\ and\\:\\ 0\\.003396396334570159\ \(0\)\
\-\ measuring\\:\\ 0\\.0033936005188170263\ \(0\)\
\-\ enlargement\\:\\ 0\\.0033669994106108195\ \(0\)\
\-\ moderate\\:\\ 0\\.0033368394325807315\ \(0\)\
\-\ pressure\\:\\ 0\\.00333260467708276\ \(0\)\
\-\ base\\:\\ 0\\.0033241889601105926\ \(0\)\
\-\ er\\:\\ 0\\.003255396382272057\ \(0\)\
\-\ result\\:\\ 0\\.003255396382272057\ \(0\)\
\-\ of\\:\\ 0\\.0032394304094773346\ \(0\)\
\-\ effusion\\:\\ 0\\.0032246017082476677\ \(0\)\
\-\ occur\\:\\ 0\\.0031837603066350926\ \(0\)\
\-\ ventricle\\:\\ 0\\.0031801294116965517\ \(0\)\
\-\ studies\\:\\ 0\\.003169315707824389\ \(0\)\
\-\ which\\:\\ 0\\.0031681123877707025\ \(0\)\
\-\ a\\:\\ 0\\.0031507432120643597\ \(0\)\
\-\ laboratory\\:\\ 0\\.0031272013265680894\ \(0\)\
\-\ abnormalities\\:\\ 0\\.003116945999700314\ \(0\)\
\-\ above\\:\\ 0\\.003110167484238149\ \(0\)\
\-\ sinus\\:\\ 0\\.003103434925166274\ \(0\)\
\-\ early\\:\\ 0\\.003103434925166274\ \(0\)\
\-\ risk\\:\\ 0\\.003073690811677345\ \(0\)\
\-\ weight\\:\\ 0\\.0030416542057009584\ \(0\)\
\-\ being\\:\\ 0\\.0029570883582925108\ \(0\)\
\-\ labs\\:\\ 0\\.0029513148033119543\ \(0\)\
\-\ was\\:\\ 0\\.0029442230056018477\ \(0\)\
\-\ that\\:\\ 0\\.0029314413675448326\ \(0\)\
\-\ presentation\\:\\ 0\\.0029229400541122964\ \(0\)\
\-\ 3\\.\\:\\ 0\\.0029035493665747042\ \(0\)\
\-\ air\\:\\ 0\\.0028711644752253884\ \(0\)\
\-\ first\\:\\ 0\\.0028475505807208064\ \(0\)\
\-\ by\\:\\ 0\\.0028259600858885296\ \(0\)\
\-\ white\\:\\ 0\\.002814403388989094\ \(0\)\
\-\ vascular\\:\\ 0\\.002782326979070205\ \(0\)\
\-\ positive\\:\\ 0\\.0027536103180577126\ \(0\)\
\-\ several\\:\\ 0\\.002727996857718359\ \(0\)\
\-\ should\\:\\ 0\\.0027052716404059583\ \(0\)\
\-\ 2\\.\\:\\ 0\\.0026985542619664925\ \(0\)\
\-\ known\\:\\ 0\\.0026852543043334853\ \(0\)\
\-\ any\\:\\ 0\\.002672130122216776\ \(0\)\
\-\ such\\:\\ 0\\.0026527634457208064\ \(0\)\
\-\ 1\\.\\:\\ 0\\.002650634723234956\ \(0\)\
\-\ approximately\\:\\ 0\\.0026254397483173614\ \(0\)\
\-\ severe\\:\\ 0\\.002611032572061573\ \(0\)\
\-\ usually\\:\\ 0\\.002576890023700853\ \(0\)\
\-\ patient\\:\\ 0\\.0025519124059078095\ \(0\)\
\-\ only\\:\\ 0\\.0025515508028648814\ \(0\)\
\-\ month\\:\\ 0\\.002545793982920168\ \(0\)\
\-\ treated\\:\\ 0\\.002540070343678112\ \(0\)\
\-\ there\\:\\ 0\\.002525750856931457\ \(0\)\
\-\ lung\\:\\ 0\\.0024579534461159347\ \(0\)\
\-\ two\\:\\ 0\\.002430319004583918\ \(0\)\
\-\ abnormal\\:\\ 0\\.002420151182040627\ \(0\)\
\-\ all\\:\\ 0\\.002400122631014191\ \(0\)\
\-\ chronic\\:\\ 0\\.002390257828110228\ \(0\)\
\-\ she\\:\\ 0\\.002382111361920727\ \(0\)\
\-\ however\\:\\ 0\\.0023628282577925225\ \(0\)\
\-\ high\\:\\ 0\\.00232229003086079\ \(0\)\
\-\ months\\:\\ 0\\.0023177172737736517\ \(0\)\
\-\ are\\:\\ 0\\.0023135528749346607\ \(0\)\
\-\ been\\:\\ 0\\.002308634448325711\ \(0\)\
\-\ if\\:\\ 0\\.002302625058372031\ \(0\)\
\-\ significant\\:\\ 0\\.002281874032824452\ \(0\)\
\-\ cm\\:\\ 0\\.0022760239501658248\ \(0\)\
\-\ than\\:\\ 0\\.002223484463672566\ \(0\)\
\-\ who\\:\\ 0\\.0022124810418487607\ \(0\)\
\-\ both\\:\\ 0\\.0021670307752593063\ \(0\)\
\-\ into\\:\\ 0\\.002019192023793155\ \(0\)\
\-\ noted\\:\\ 0\\.0020113417958814235\ \(0\)\
\-\ \\;\\:\\ 0\\.0020113417958814235\ \(0\)\
\-\ associated\\:\\ 0\\.0020024454438010942\ \(0\)\
\-\ 3\\:\\ 0\\.0019870660642567423\ \(0\)\
\-\ most\\:\\ 0\\.0019591212926793207\ \(0\)\
\-\ small\\:\\ 0\\.0019548910470517564\ \(0\)\
\-\ were\\:\\ 0\\.00192679874547162\ \(0\)\
\-\ well\\:\\ 0\\.001919643448826863\ \(0\)\
\-\ this\\:\\ 0\\.0019089120423319424\ \(0\)\
\-\ contrast\\:\\ 0\\.0018994793314874928\ \(0\)\
\-\ after\\:\\ 0\\.001755711224040916\ \(0\)\
\-\ female\\:\\ 0\\.0017445484324208874\ \(0\)\
\-\ treatment\\:\\ 0\\.0017175938029800268\ \(0\)\
\-\ no\\:\\ 0\\.0017089258206629632\ \(0\)\
\-\ also\\:\\ 0\\.0016729092290666844\ \(0\)\
\-\ on\\:\\ 0\\.0014377179987396784\ \(0\)\
\-\ disease\\:\\ 0\\.0013870283428159922\ \(0\)\
\-\ \\.\\:\\ 0\\.001339605135748916\ \(0\)\
\-\ with\\:\\ 0\\.001278099242292738\ \(0\)\
\-\ not\\:\\ 0\\.001226235026556043\ \(0\)\
\-\ at\\:\\ 0\\.0011497151468040049\ \(0\)\
\-\ year\\:\\ 0\\.0009494590558817425\ \(0\)\
\-\ old\\:\\ 0\\.0008688526284630135\ \(0\)\
